Gabapentin Tablet
Product Images NDC 64380-727

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64380-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1a2df8de F3dd 43d5 983b 28151463babc 01)

FDA Label Image

Figure 1 (1a2df8de F3dd 43d5 983b 28151463babc 02)

This text provides information about a study involving a 4-week dose titration period followed by a 4-week fixed dose period. It mentions a placebo and Gabapentin at a dosage of 3600 mg/day. Additionally, it includes a mean pain score of 10.*

FDA Label Image

Figure 2 (1a2df8de F3dd 43d5 983b 28151463babc 03)

FDA Label Image

Figure 3 (1a2df8de F3dd 43d5 983b 28151463babc 04)

This text provides information regarding the preparation of responders (patients with a 50% reduction in pain score) at the endpoint in Controlled PHN Studies. It includes data from two studies showing the percentage of responders in Study 1 as 34% and Study 2 as 29%. Additionally, it includes the names of different medications or treatments such as GEP 3600, GBP 1800, and GBF 2400.*

FDA Label Image

Figure 2 (1a2df8de F3dd 43d5 983b 28151463babc 05)

FDA Label Image

600mg-100s (1a2df8de F3dd 43d5 983b 28151463babc 06)

FDA Label Image

800mg-100s (1a2df8de F3dd 43d5 983b 28151463babc 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.